Cargando…
Control of Advanced Cancer: The Road to Chronicity
Despite the recent trend toward a slight decrease in age-adjusted cancer mortality in some countries, crude mortality rates will continue to increase, driven by the demographic shift towards an aged population. Small molecules (small molecules and biologics) are not only a new therapeutic acquisitio...
Autores principales: | Lage, Agustin, Crombet, Tania |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083664/ https://www.ncbi.nlm.nih.gov/pubmed/21556173 http://dx.doi.org/10.3390/ijerph8030683 |
Ejemplares similares
-
The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer
por: Crombet Ramos, Tania, et al.
Publicado: (2021) -
Is there a subgroup of long-term evolution among patients with advanced lung cancer?: Hints from the analysis of survival curves from cancer registry data
por: Sanchez, Lizet, et al.
Publicado: (2014) -
COVID-19 and Cancer in Cuba
por: Rubio, Maria Caridad, et al.
Publicado: (2020) -
Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients
por: Rodriguez, Pedro C, et al.
Publicado: (2011) -
CIMAvax-EGF: A New Therapeutic Vaccine for Advanced Non-Small Cell Lung Cancer Patients
por: Saavedra, Danay, et al.
Publicado: (2017)